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An organism’s behaviour represents the complex culmination of its genetics, the 
environments it experiences throughout its life, and stochastic developmental processes. One 
of the key goals in biology has been to understand, at the molecular level, how exposure to 
particular experiences can interact with genetics to give rise to individualised behaviour 
patterns. For example, we know that, although monozygotic twins share exactly the same 
DNA, they can be quite divergent in how they think and act (Haque et al., 2009).   
 
Over the past 30 years, work in the field of epigenetics has started to systematically address 
this question. Epigenetics is the study of chemical marks which affect the structure and 
expression of the genome, without altering its sequence. In the strictest sense, the term 
‘epigenetic’ should only be used to describe those marks which are heritable across cellular 
divisions; now however, it is used more fluidly (and controversially) to cover a range of 
processes, including those which might technically be more accurately referred to as 
‘transcriptional regulation’ (Deans and Maggert, 2015). Epigenetic marks range from those 
which modify the DNA at discrete sites (notably methylation or hydroxymethylation at CpG 
dinucleotides), to modification of the histone proteins involved in local chromatin structure 
(often via acetylation or methylation), to non-coding RNAs which can coat extensive genomic 
regions. Importantly, epigenetic marks are labile and can be affected by the cellular milieu; 
hence, they represent a fascinating molecular nexus between an organism’s genetics and its 
environment.  
 
Epigenetic studies may provide insights into how the unique genetic and environmental 
factors experienced by an individual can influence behavioural and cognitive processes, for 
example with respect to personality and memory function (Sweatt). However, often 
behavioural epigenetic studies are correlational (identifying differences in epigenetic 
signatures between phenotypically-distinct groups which may not necessarily be causal), and 
rely on epigenetic information obtained from peripheral tissues rather than brain. The use of 
model systems, in which environmental exposures can be controlled and where brain tissue 
can be readily accessed, can circumvent these issues. Here, McCarthy reviews recent work in 
rodents in which epigenetic effects (notably in the preoptic area of the hypothalamus) are 
shown to mediate the development of sexually-dimorphic behaviours, whilst Anreiter et al. 
review advances in understanding the relationship between epigenetic signatures and 
behaviour in the invertebrate fruitfly Drosophila melanogaster. Whether the associations and 
processes observed in these systems are also seen in humans remains to be tested.  
 
We know from genetic studies that genes encoding mediators of epigenetic processes seem 
to be disproportionately highly-mutated in developmental and psychiatric disorders 
(Mastrototaro et al., 2017; Network and Pathway Analysis Subgroup of Psychiatric Genomics 
Consortium, 2015); hence, as well as being useful for understanding normal variation in 
behavioural function, epigenetic studies may also be relevant for understanding the biology 
of pathological conditions. Work in this area is particularly challenging, as distinct epigenetic 
signatures between healthy individuals and individuals with a psychiatric diagnosis may be 
causal, or may simply reflect differential environmental exposures across groups (e.g. 
increased rates of smoking, stress, general poor health or drug consumption in cases 
compared to controls). On a more positive note, access to large samples of brain tissue from 
patient cohorts is becoming increasingly feasible, allowing more biologically (and 
therapeutically) meaningful links between neural epigenetic signatures and disorder status to 
be discovered. Here, Bastle and Maze describes new findings regarding how chromatin 
regulation may influence the risk of multiple brain disorders, whilst Migdalska-Richards and 
Mill focus on exciting new work identifying epigenetic signatures associated with 
schizophrenia in peripheral and brain tissues. Two review papers then touch on the 
fascinating overlap between circadian biology and depression and the epigenetic signatures 
underlying these (Shi and Johnson and Sato and Sassone-Corsi), with a view to characterising 
potential novel therapeutic strategies.  
 
One of the most interesting, and controversial, areas of research in behavioural epigenetics 
over the past few years has been the inter-generational transmission of behavioural 
phenotypes. For example, good and bad rodent mothers may differentially affect the 
epigenetic status of genes involved in the stress response in their offspring (and subsequent 
offspring behaviour) via high or low levels of maternal care respectively (Weaver et al., 2004). 
Alternatively, situations experienced by parents may be encoded epigenetically in the 
germline, and may, ultimately, lead to altered behaviour in offspring (Dias and Ressler, 2014). 
Jawaid and Mansuy critically review some of these animal model studies, as well as examining 
the concept that inheritance of epigenetic correlates of parental experiences may occur in 
humans.   
    
DNA in the paternal and maternal germlines is differentially epigenetically-marked, hence the 
need for a parent of either sex to produce viable offspring. In the offspring, whilst most genes 
are equally expressed from their paternal and maternal copies, epigenetic processes ensure 
that a handful of genes are only expressed from the paternally-inherited copy, and a small 
number of genes only from their maternally-inherited copy. These so-called ‘imprinted genes’ 
are known to regulate important developmental processes, and there is an increasing 
recognition of their important role in neurodevelopment and behaviour (Wilkinson et al., 
2007). Prader-Willi syndrome (PWS) is a neuroendocrine condition caused by loss-of-function 
of paternally expressed genes on chromosome 15q11-13, and is characterised by an impaired 
satiety response; Whittington and Holland review the complex range of neurobehavioural 
issues in individuals affected by PWS and examine genotype-phenotype correlations. 
Interestingly, individuals with PWS as a consequence of a maternal duplication of 15q11-13 
are more likely to exhibit psychotic phenotypes than individuals with other genetic mutations. 
Crespi critically reviews the evidence that paternally and maternally expressed imprinted 
genes more generally may be oppositely associated with developmental and psychiatric 
disorder risk. The behavioural phenotype of patients with PWS is likely to be influenced, in 
part, by imprinted small non-coding RNAs; these molecular regulators are likely to influence 
a range of other normal and aberrant brain functions, and their established roles have been 
comprehensively reviewed by Marty and Cavaille.  
 
Whilst the functions of imprinted genes such as those within the PWS interval, are relatively 
well-understood, there is not yet a concensus as to how many (and which) genes are 
imprinted, and exactly what processes they regulate. Ho-Shing and Dulac describe emerging 
work, primarily in elegant mouse models, which has screened for, and identified, novel 
imprinted genes and which has begun to dissect their biological functions. More focussed, 
single gene led work covered by Isles et al. has highlighted imprinted genes as potential 
mediators of offspring behavioural phenotypes following early-life adversity, whilst work 
assessed here by Lassi and Tucci has implicated imprinted genes in sleep processes. The 
evolutionary pressures which have led to the establishment and maintenance of genomic 
imprinting in mammals remain to be clarified. Theoretically, genomic imprinting could be 
influenced by, and influence, dispersal processes (Hitchcock and Gardner).   
 
The reviews in this Special Issue serve to highlight the fact that we are currently at the very 
early stages of understanding how epigenetic mechanisms, including genomic imprinting, are 
associated with, and might be causal for, behavioural phenotypes and disorder risk. Over the 
next decade, we expect to see a substantial improvement in the efficacy and accuracy with 
which we can interrogate the complete epigenome, as well as in the availability of highly-
selective epigenome-modifying drugs and manipulations permitting tests of causality.      
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